Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:06 AM
Ignite Modification Date:
2025-12-25 @ 2:06 AM
NCT ID:
NCT02046460
Eligibility Criteria:
Inclusion Criteria:
1. Acute ischemic or non-ischemic symptoms within 2 weeks
2. Verification of CAD-diagnosis (carotid and/or vertebral) by MR-techniques (at least one):
* mural hematoma or
* pseudo-aneurysm or
* long filiform stenosis or
* intimal flap or
* double lumen or
* occlusion situated more than 2 cm above the bifurcation of the carotid artery, revealing a pseudo aneurysm or a long filiform stenosis after recanalisation.
3. Written informed consent by patient or next-to-kin
4. 24h latency period in case of thrombolysis
5. Age \> 18 years by time of inclusion
Exclusion Criteria:
1. MR-contraindications (claustrophobia precluding MRI: patients agreeing to undergo MRI scanning with mild sedation may be entered into the study)
2. Contraindications to the use of anticoagulation (vitamin k antagonists, heparin) or ASA (according to the Swiss "Arzneimittelkompendium" http://www.compendium.ch/search/de or the "Rote Liste" (German centers) or "Lægemiddelstyrelsen - produktresume" for the Danish center (https://laegemiddelstyrelsen.dk/da/bivirkninger/find-medicin/produktresumeer/) and the judgment of the treating physician)
3. Pregnancy (Note: for women in child bearing age a pregnancy test has to be done prior to study entry)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02046460
Study Brief:
Protocol Section:
NCT02046460